Albuterol HFAs Could Face Generic Competition By 2010, FDA Final Rule Says
Executive Summary
Branded hydrofluoroalkane albuterol products may have as little as one year between the withdrawal of CFC-containing inhalers and the entry of HFA generics, according to FDA's analysis
You may also be interested in...
CFC Albuterol To Be Pulled In 2008; FDA Says HFA Makers Need Ramp-Up Time
FDA is basing its Dec. 31, 2008 deadline for the withdrawal of CFC-containing albuterol on the concern that manufacturers will need additional time to ramp-up production of hydrofluoroalkane products
CFC Albuterol To Be Pulled In 2008; FDA Says HFA Makers Need Ramp-Up Time
FDA is basing its Dec. 31, 2008 deadline for the withdrawal of CFC-containing albuterol on the concern that manufacturers will need additional time to ramp-up production of hydrofluoroalkane products
GSK Offers Price Freeze On Ventolin HFA In Bid For Early Phase-Out Of CFCs
GlaxoSmithKline has offered to freeze the wholesale price of its Ventolin HFA inhaler as part of its case for FDA to phase out chlorofluorocarbon albuterol metered-dose inhalers by December 31, 2005